[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Global Ankylosing Spondylitis Industry Research Report, Competitive Landscape, Market Size, Regional Status and Prospect

May 2023 | 124 pages | ID: G4F8131E776FEN
Maia Research

US$ 3,250.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
The report combines extensive quantitative analysis and exhaustive qualitative analysis, ranges from a macro overview of the total market size, industry chain, and market dynamics to micro details of segment markets by type, application and region, and, as a result, provides a holistic view of, as well as a deep insight into the Ankylosing Spondylitis market covering all its essential aspects.

For the competitive landscape, the report also introduces players in the industry from the perspective of the market share, concentration ratio, etc., and describes the leading companies in detail, with which the readers can get a better idea of their competitors and acquire an in-depth understanding of the competitive situation. Further, mergers & acquisitions, emerging market trends, the impact of COVID-19, and regional conflicts will all be considered.

In a nutshell, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the market in any manner.

Key players in the global Ankylosing Spondylitis market are covered in Chapter 9:

Shanghai Pharmaceuticals
UCB
Novartis
Pfizer
Boehringer Ingelheim
Sanofi
Celgene
Otsuka Pharmaceutical
Merck & Co.
Abbvie
F. Hoffmann-La Roche
Regeneron Pharmaceuticals
Celltrion
Bristol-Myers Squibb
Eisai
Amgen
Janssen Pharmaceuticals
Merck Sharp & Dohme

In Chapter 5 and Chapter 7.3, based on types, the Ankylosing Spondylitis market from 2017 to 2027 is primarily split into:

TNF Inhibitors
COX Inhibitors
Others


In Chapter 6 and Chapter 7.4, based on applications, the Ankylosing Spondylitis market from 2017 to 2027 covers:

Oral
Parenteral

Geographically, the detailed analysis of consumption, revenue, market share and growth rate, historical data and forecast (2017-2027) of the following regions are covered in Chapter 4 and Chapter 7:

United States
Europe
China
Japan
India
Southeast Asia
Latin America
Middle East and Africa

Client Focus

1. Does this report consider the impact of COVID-19 and the Russia-Ukraine war on the Ankylosing Spondylitis market?

Yes. As the COVID-19 and the Russia-Ukraine war are profoundly affecting the global supply chain relationship and raw material price system, we have definitely taken them into consideration throughout the research, and in Chapters 1.7, 2.7, 4.X.1, 7.5, 8.7, we elaborate at full length on the impact of the pandemic and the war on the Ankylosing Spondylitis Industry.

2. How do you determine the list of the key players included in the report?

With the aim of clearly revealing the competitive situation of the industry, we concretely analyze not only the leading enterprises that have a voice on a global scale, but also the regional small and medium-sized companies that play key roles and have plenty of potential growth.

Please find the key player list in Summary.

3. What are your main data sources?

Both Primary and Secondary data sources are being used while compiling the report.

Primary sources include extensive interviews of key opinion leaders and industry experts (such as experienced front-line staff, directors, CEOs, and marketing executives), downstream distributors, as well as end-users.

Secondary sources include the research of the annual and financial reports of the top companies, public files, new journals, etc. We also cooperate with some third-party databases.

Please find a more complete list of data sources in Chapters 11.2.1 & 11.2.2.

4. Can I modify the scope of the report and customize it to suit my requirements?

Yes. Customized requirements of multi-dimensional, deep-level and high-quality can help our customers precisely grasp market opportunities, effortlessly confront market challenges, properly formulate market strategies and act promptly, thus to win them sufficient time and space for market competition.

Outline

Chapter 1 mainly defines the market scope and introduces the macro overview of the industry, with an executive summary of different market segments ((by type, application, region, etc.), including the definition, market size, and trend of each market segment.

Chapter 2 provides a qualitative analysis of the current status and future trends of the market. Industry Entry Barriers, market drivers, market challenges, emerging markets, consumer preference analysis, together with the impact of the COVID-19 outbreak will all be thoroughly explained.

Chapter 3 analyzes the current competitive situation of the market by providing data regarding the players, including their sales volume and revenue with corresponding market shares, price and gross margin. In addition, information about market concentration ratio, mergers, acquisitions, and expansion plans will also be covered.

Chapter 4 focuses on the regional market, presenting detailed data (i.e., sales volume, revenue, price, gross margin) of the most representative regions and countries in the world.

Chapter 5 provides the analysis of various market segments according to product types, covering sales volume, revenue along with market share and growth rate, plus the price analysis of each type.

Chapter 6 shows the breakdown data of different applications, including the consumption and revenue with market share and growth rate, with the aim of helping the readers to take a close-up look at the downstream market.

Chapter 7 provides a combination of quantitative and qualitative analyses of the market size and development trends in the next five years. The forecast information of the whole, as well as the breakdown market, offers the readers a chance to look into the future of the industry.

Chapter 8 is the analysis of the whole market industrial chain, covering key raw materials suppliers and price analysis, manufacturing cost structure analysis, alternative product analysis, also providing information on major distributors, downstream buyers, and the impact of COVID-19 pandemic.

Chapter 9 shares a list of the key players in the market, together with their basic information, product profiles, market performance (i.e., sales volume, price, revenue, gross margin), recent development, SWOT analysis, etc.

Chapter 10 is the conclusion of the report which helps the readers to sum up the main findings and points.

Chapter 11 introduces the market research methods and data sources.

Years considered for this report:

Historical Years: 2017-2021
Base Year: 2021
Estimated Year: 2022
Forecast Period: 2022-2027
1 ANKYLOSING SPONDYLITIS MARKET OVERVIEW

1.1 Product Overview and Scope of Ankylosing Spondylitis Market
1.2 Ankylosing Spondylitis Market Segment by Type
  1.2.1 Global Ankylosing Spondylitis Market Sales Volume and CAGR (%) Comparison by Type (2017-2027)
1.3 Global Ankylosing Spondylitis Market Segment by Application
  1.3.1 Ankylosing Spondylitis Market Consumption (Sales Volume) Comparison by Application (2017-2027)
1.4 Global Ankylosing Spondylitis Market, Region Wise (2017-2027)
  1.4.1 Global Ankylosing Spondylitis Market Size (Revenue) and CAGR (%) Comparison by Region (2017-2027)
  1.4.2 United States Ankylosing Spondylitis Market Status and Prospect (2017-2027)
  1.4.3 Europe Ankylosing Spondylitis Market Status and Prospect (2017-2027)
  1.4.4 China Ankylosing Spondylitis Market Status and Prospect (2017-2027)
  1.4.5 Japan Ankylosing Spondylitis Market Status and Prospect (2017-2027)
  1.4.6 India Ankylosing Spondylitis Market Status and Prospect (2017-2027)
  1.4.7 Southeast Asia Ankylosing Spondylitis Market Status and Prospect (2017-2027)
  1.4.8 Latin America Ankylosing Spondylitis Market Status and Prospect (2017-2027)
  1.4.9 Middle East and Africa Ankylosing Spondylitis Market Status and Prospect (2017-2027)
1.5 Global Market Size of Ankylosing Spondylitis (2017-2027)
  1.5.1 Global Ankylosing Spondylitis Market Revenue Status and Outlook (2017-2027)
  1.5.2 Global Ankylosing Spondylitis Market Sales Volume Status and Outlook (2017-2027)
1.6 Global Macroeconomic Analysis
1.7 The impact of the Russia-Ukraine war on the Ankylosing Spondylitis Market

2 INDUSTRY OUTLOOK

2.1 Ankylosing Spondylitis Industry Technology Status and Trends
2.2 Industry Entry Barriers
  2.2.1 Analysis of Financial Barriers
  2.2.2 Analysis of Technical Barriers
  2.2.3 Analysis of Talent Barriers
  2.2.4 Analysis of Brand Barrier
2.3 Ankylosing Spondylitis Market Drivers Analysis
2.4 Ankylosing Spondylitis Market Challenges Analysis
2.5 Emerging Market Trends
2.6 Consumer Preference Analysis
2.7 Ankylosing Spondylitis Industry Development Trends under COVID-19 Outbreak
  2.7.1 Global COVID-19 Status Overview
  2.7.2 Influence of COVID-19 Outbreak on Ankylosing Spondylitis Industry Development

3 GLOBAL ANKYLOSING SPONDYLITIS MARKET LANDSCAPE BY PLAYER

3.1 Global Ankylosing Spondylitis Sales Volume and Share by Player (2017-2022)
3.2 Global Ankylosing Spondylitis Revenue and Market Share by Player (2017-2022)
3.3 Global Ankylosing Spondylitis Average Price by Player (2017-2022)
3.4 Global Ankylosing Spondylitis Gross Margin by Player (2017-2022)
3.5 Ankylosing Spondylitis Market Competitive Situation and Trends
  3.5.1 Ankylosing Spondylitis Market Concentration Rate
  3.5.2 Ankylosing Spondylitis Market Share of Top 3 and Top 6 Players
  3.5.3 Mergers & Acquisitions, Expansion

4 GLOBAL ANKYLOSING SPONDYLITIS SALES VOLUME AND REVENUE REGION WISE (2017-2022)

4.1 Global Ankylosing Spondylitis Sales Volume and Market Share, Region Wise (2017-2022)
4.2 Global Ankylosing Spondylitis Revenue and Market Share, Region Wise (2017-2022)
4.3 Global Ankylosing Spondylitis Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.4 United States Ankylosing Spondylitis Sales Volume, Revenue, Price and Gross Margin (2017-2022)
  4.4.1 United States Ankylosing Spondylitis Market Under COVID-19
4.5 Europe Ankylosing Spondylitis Sales Volume, Revenue, Price and Gross Margin (2017-2022)
  4.5.1 Europe Ankylosing Spondylitis Market Under COVID-19
4.6 China Ankylosing Spondylitis Sales Volume, Revenue, Price and Gross Margin (2017-2022)
  4.6.1 China Ankylosing Spondylitis Market Under COVID-19
4.7 Japan Ankylosing Spondylitis Sales Volume, Revenue, Price and Gross Margin (2017-2022)
  4.7.1 Japan Ankylosing Spondylitis Market Under COVID-19
4.8 India Ankylosing Spondylitis Sales Volume, Revenue, Price and Gross Margin (2017-2022)
  4.8.1 India Ankylosing Spondylitis Market Under COVID-19
4.9 Southeast Asia Ankylosing Spondylitis Sales Volume, Revenue, Price and Gross Margin (2017-2022)
  4.9.1 Southeast Asia Ankylosing Spondylitis Market Under COVID-19
4.10 Latin America Ankylosing Spondylitis Sales Volume, Revenue, Price and Gross Margin (2017-2022)
  4.10.1 Latin America Ankylosing Spondylitis Market Under COVID-19
4.11 Middle East and Africa Ankylosing Spondylitis Sales Volume, Revenue, Price and Gross Margin (2017-2022)
  4.11.1 Middle East and Africa Ankylosing Spondylitis Market Under COVID-19

5 GLOBAL ANKYLOSING SPONDYLITIS SALES VOLUME, REVENUE, PRICE TREND BY TYPE

5.1 Global Ankylosing Spondylitis Sales Volume and Market Share by Type (2017-2022)
5.2 Global Ankylosing Spondylitis Revenue and Market Share by Type (2017-2022)
5.3 Global Ankylosing Spondylitis Price by Type (2017-2022)
5.4 Global Ankylosing Spondylitis Sales Volume, Revenue and Growth Rate by Type (2017-2022)
  5.4.1 Global Ankylosing Spondylitis Sales Volume, Revenue and Growth Rate of TNF Inhibitors (2017-2022)
  5.4.2 Global Ankylosing Spondylitis Sales Volume, Revenue and Growth Rate of COX Inhibitors (2017-2022)
  5.4.3 Global Ankylosing Spondylitis Sales Volume, Revenue and Growth Rate of Others (2017-2022)

6 GLOBAL ANKYLOSING SPONDYLITIS MARKET ANALYSIS BY APPLICATION

6.1 Global Ankylosing Spondylitis Consumption and Market Share by Application (2017-2022)
6.2 Global Ankylosing Spondylitis Consumption Revenue and Market Share by Application (2017-2022)
6.3 Global Ankylosing Spondylitis Consumption and Growth Rate by Application (2017-2022)
  6.3.1 Global Ankylosing Spondylitis Consumption and Growth Rate of Oral (2017-2022)
  6.3.2 Global Ankylosing Spondylitis Consumption and Growth Rate of Parenteral (2017-2022)

7 GLOBAL ANKYLOSING SPONDYLITIS MARKET FORECAST (2022-2027)

7.1 Global Ankylosing Spondylitis Sales Volume, Revenue Forecast (2022-2027)
  7.1.1 Global Ankylosing Spondylitis Sales Volume and Growth Rate Forecast (2022-2027)
  7.1.2 Global Ankylosing Spondylitis Revenue and Growth Rate Forecast (2022-2027)
  7.1.3 Global Ankylosing Spondylitis Price and Trend Forecast (2022-2027)
7.2 Global Ankylosing Spondylitis Sales Volume and Revenue Forecast, Region Wise (2022-2027)
  7.2.1 United States Ankylosing Spondylitis Sales Volume and Revenue Forecast (2022-2027)
  7.2.2 Europe Ankylosing Spondylitis Sales Volume and Revenue Forecast (2022-2027)
  7.2.3 China Ankylosing Spondylitis Sales Volume and Revenue Forecast (2022-2027)
  7.2.4 Japan Ankylosing Spondylitis Sales Volume and Revenue Forecast (2022-2027)
  7.2.5 India Ankylosing Spondylitis Sales Volume and Revenue Forecast (2022-2027)
  7.2.6 Southeast Asia Ankylosing Spondylitis Sales Volume and Revenue Forecast (2022-2027)
  7.2.7 Latin America Ankylosing Spondylitis Sales Volume and Revenue Forecast (2022-2027)
  7.2.8 Middle East and Africa Ankylosing Spondylitis Sales Volume and Revenue Forecast (2022-2027)
7.3 Global Ankylosing Spondylitis Sales Volume, Revenue and Price Forecast by Type (2022-2027)
  7.3.1 Global Ankylosing Spondylitis Revenue and Growth Rate of TNF Inhibitors (2022-2027)
  7.3.2 Global Ankylosing Spondylitis Revenue and Growth Rate of COX Inhibitors (2022-2027)
  7.3.3 Global Ankylosing Spondylitis Revenue and Growth Rate of Others (2022-2027)
7.4 Global Ankylosing Spondylitis Consumption Forecast by Application (2022-2027)
  7.4.1 Global Ankylosing Spondylitis Consumption Value and Growth Rate of Oral(2022-2027)
  7.4.2 Global Ankylosing Spondylitis Consumption Value and Growth Rate of Parenteral(2022-2027)
7.5 Ankylosing Spondylitis Market Forecast Under COVID-19

8 ANKYLOSING SPONDYLITIS MARKET UPSTREAM AND DOWNSTREAM ANALYSIS

8.1 Ankylosing Spondylitis Industrial Chain Analysis
8.2 Key Raw Materials Suppliers and Price Analysis
8.3 Manufacturing Cost Structure Analysis
  8.3.1 Labor Cost Analysis
  8.3.2 Energy Costs Analysis
  8.3.3 R&D Costs Analysis
8.4 Alternative Product Analysis
8.5 Major Distributors of Ankylosing Spondylitis Analysis
8.6 Major Downstream Buyers of Ankylosing Spondylitis Analysis
8.7 Impact of COVID-19 and the Russia-Ukraine war on the Upstream and Downstream in the Ankylosing Spondylitis Industry

9 PLAYERS PROFILES

9.1 Shanghai Pharmaceuticals
  9.1.1 Shanghai Pharmaceuticals Basic Information, Manufacturing Base, Sales Region and Competitors
  9.1.2 Ankylosing Spondylitis Product Profiles, Application and Specification
  9.1.3 Shanghai Pharmaceuticals Market Performance (2017-2022)
  9.1.4 Recent Development
  9.1.5 SWOT Analysis
9.2 UCB
  9.2.1 UCB Basic Information, Manufacturing Base, Sales Region and Competitors
  9.2.2 Ankylosing Spondylitis Product Profiles, Application and Specification
  9.2.3 UCB Market Performance (2017-2022)
  9.2.4 Recent Development
  9.2.5 SWOT Analysis
9.3 Novartis
  9.3.1 Novartis Basic Information, Manufacturing Base, Sales Region and Competitors
  9.3.2 Ankylosing Spondylitis Product Profiles, Application and Specification
  9.3.3 Novartis Market Performance (2017-2022)
  9.3.4 Recent Development
  9.3.5 SWOT Analysis
9.4 Pfizer
  9.4.1 Pfizer Basic Information, Manufacturing Base, Sales Region and Competitors
  9.4.2 Ankylosing Spondylitis Product Profiles, Application and Specification
  9.4.3 Pfizer Market Performance (2017-2022)
  9.4.4 Recent Development
  9.4.5 SWOT Analysis
9.5 Boehringer Ingelheim
  9.5.1 Boehringer Ingelheim Basic Information, Manufacturing Base, Sales Region and Competitors
  9.5.2 Ankylosing Spondylitis Product Profiles, Application and Specification
  9.5.3 Boehringer Ingelheim Market Performance (2017-2022)
  9.5.4 Recent Development
  9.5.5 SWOT Analysis
9.6 Sanofi
  9.6.1 Sanofi Basic Information, Manufacturing Base, Sales Region and Competitors
  9.6.2 Ankylosing Spondylitis Product Profiles, Application and Specification
  9.6.3 Sanofi Market Performance (2017-2022)
  9.6.4 Recent Development
  9.6.5 SWOT Analysis
9.7 Celgene
  9.7.1 Celgene Basic Information, Manufacturing Base, Sales Region and Competitors
  9.7.2 Ankylosing Spondylitis Product Profiles, Application and Specification
  9.7.3 Celgene Market Performance (2017-2022)
  9.7.4 Recent Development
  9.7.5 SWOT Analysis
9.8 Otsuka Pharmaceutical
  9.8.1 Otsuka Pharmaceutical Basic Information, Manufacturing Base, Sales Region and Competitors
  9.8.2 Ankylosing Spondylitis Product Profiles, Application and Specification
  9.8.3 Otsuka Pharmaceutical Market Performance (2017-2022)
  9.8.4 Recent Development
  9.8.5 SWOT Analysis
9.9 Merck & Co.
  9.9.1 Merck & Co. Basic Information, Manufacturing Base, Sales Region and Competitors
  9.9.2 Ankylosing Spondylitis Product Profiles, Application and Specification
  9.9.3 Merck & Co. Market Performance (2017-2022)
  9.9.4 Recent Development
  9.9.5 SWOT Analysis
9.10 Abbvie
  9.10.1 Abbvie Basic Information, Manufacturing Base, Sales Region and Competitors
  9.10.2 Ankylosing Spondylitis Product Profiles, Application and Specification
  9.10.3 Abbvie Market Performance (2017-2022)
  9.10.4 Recent Development
  9.10.5 SWOT Analysis
9.11 F. Hoffmann-La Roche
  9.11.1 F. Hoffmann-La Roche Basic Information, Manufacturing Base, Sales Region and Competitors
  9.11.2 Ankylosing Spondylitis Product Profiles, Application and Specification
  9.11.3 F. Hoffmann-La Roche Market Performance (2017-2022)
  9.11.4 Recent Development
  9.11.5 SWOT Analysis
9.12 Regeneron Pharmaceuticals
  9.12.1 Regeneron Pharmaceuticals Basic Information, Manufacturing Base, Sales Region and Competitors
  9.12.2 Ankylosing Spondylitis Product Profiles, Application and Specification
  9.12.3 Regeneron Pharmaceuticals Market Performance (2017-2022)
  9.12.4 Recent Development
  9.12.5 SWOT Analysis
9.13 Celltrion
  9.13.1 Celltrion Basic Information, Manufacturing Base, Sales Region and Competitors
  9.13.2 Ankylosing Spondylitis Product Profiles, Application and Specification
  9.13.3 Celltrion Market Performance (2017-2022)
  9.13.4 Recent Development
  9.13.5 SWOT Analysis
9.14 Bristol-Myers Squibb
  9.14.1 Bristol-Myers Squibb Basic Information, Manufacturing Base, Sales Region and Competitors
  9.14.2 Ankylosing Spondylitis Product Profiles, Application and Specification
  9.14.3 Bristol-Myers Squibb Market Performance (2017-2022)
  9.14.4 Recent Development
  9.14.5 SWOT Analysis
9.15 Eisai
  9.15.1 Eisai Basic Information, Manufacturing Base, Sales Region and Competitors
  9.15.2 Ankylosing Spondylitis Product Profiles, Application and Specification
  9.15.3 Eisai Market Performance (2017-2022)
  9.15.4 Recent Development
  9.15.5 SWOT Analysis
9.16 Amgen
  9.16.1 Amgen Basic Information, Manufacturing Base, Sales Region and Competitors
  9.16.2 Ankylosing Spondylitis Product Profiles, Application and Specification
  9.16.3 Amgen Market Performance (2017-2022)
  9.16.4 Recent Development
  9.16.5 SWOT Analysis
9.17 Janssen Pharmaceuticals
  9.17.1 Janssen Pharmaceuticals Basic Information, Manufacturing Base, Sales Region and Competitors
  9.17.2 Ankylosing Spondylitis Product Profiles, Application and Specification
  9.17.3 Janssen Pharmaceuticals Market Performance (2017-2022)
  9.17.4 Recent Development
  9.17.5 SWOT Analysis
9.18 Merck Sharp & Dohme
  9.18.1 Merck Sharp & Dohme Basic Information, Manufacturing Base, Sales Region and Competitors
  9.18.2 Ankylosing Spondylitis Product Profiles, Application and Specification
  9.18.3 Merck Sharp & Dohme Market Performance (2017-2022)
  9.18.4 Recent Development
  9.18.5 SWOT Analysis

10 RESEARCH FINDINGS AND CONCLUSION

11 APPENDIX

11.1 Methodology
11.2 Research Data Source
LIST OF TABLES AND FIGURES

Figure Ankylosing Spondylitis Product Picture
Table Global Ankylosing Spondylitis Market Sales Volume and CAGR (%) Comparison by Type
Table Ankylosing Spondylitis Market Consumption (Sales Volume) Comparison by Application (2017-2027)
Figure Global Ankylosing Spondylitis Market Size (Revenue, Million USD) and CAGR (%) (2017-2027)
Figure United States Ankylosing Spondylitis Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure Europe Ankylosing Spondylitis Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure China Ankylosing Spondylitis Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure Japan Ankylosing Spondylitis Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure India Ankylosing Spondylitis Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure Southeast Asia Ankylosing Spondylitis Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure Latin America Ankylosing Spondylitis Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure Middle East and Africa Ankylosing Spondylitis Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure Global Ankylosing Spondylitis Market Sales Volume Status and Outlook (2017-2027)
Table Global Macroeconomic Analysis
Figure Global COVID-19 Status Overview
Table Influence of COVID-19 Outbreak on Ankylosing Spondylitis Industry Development
Table Global Ankylosing Spondylitis Sales Volume by Player (2017-2022)
Table Global Ankylosing Spondylitis Sales Volume Share by Player (2017-2022)
Figure Global Ankylosing Spondylitis Sales Volume Share by Player in 2021
Table Ankylosing Spondylitis Revenue (Million USD) by Player (2017-2022)
Table Ankylosing Spondylitis Revenue Market Share by Player (2017-2022)
Table Ankylosing Spondylitis Price by Player (2017-2022)
Table Ankylosing Spondylitis Gross Margin by Player (2017-2022)
Table Mergers & Acquisitions, Expansion Plans
Table Global Ankylosing Spondylitis Sales Volume, Region Wise (2017-2022)
Table Global Ankylosing Spondylitis Sales Volume Market Share, Region Wise (2017-2022)
Figure Global Ankylosing Spondylitis Sales Volume Market Share, Region Wise (2017-2022)
Figure Global Ankylosing Spondylitis Sales Volume Market Share, Region Wise in 2021
Table Global Ankylosing Spondylitis Revenue (Million USD), Region Wise (2017-2022)
Table Global Ankylosing Spondylitis Revenue Market Share, Region Wise (2017-2022)
Figure Global Ankylosing Spondylitis Revenue Market Share, Region Wise (2017-2022)
Figure Global Ankylosing Spondylitis Revenue Market Share, Region Wise in 2021
Table Global Ankylosing Spondylitis Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table United States Ankylosing Spondylitis Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table Europe Ankylosing Spondylitis Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table China Ankylosing Spondylitis Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table Japan Ankylosing Spondylitis Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table India Ankylosing Spondylitis Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table Southeast Asia Ankylosing Spondylitis Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table Latin America Ankylosing Spondylitis Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table Middle East and Africa Ankylosing Spondylitis Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table Global Ankylosing Spondylitis Sales Volume by Type (2017-2022)
Table Global Ankylosing Spondylitis Sales Volume Market Share by Type (2017-2022)
Figure Global Ankylosing Spondylitis Sales Volume Market Share by Type in 2021
Table Global Ankylosing Spondylitis Revenue (Million USD) by Type (2017-2022)
Table Global Ankylosing Spondylitis Revenue Market Share by Type (2017-2022)
Figure Global Ankylosing Spondylitis Revenue Market Share by Type in 2021
Table Ankylosing Spondylitis Price by Type (2017-2022)
Figure Global Ankylosing Spondylitis Sales Volume and Growth Rate of TNF Inhibitors (2017-2022)
Figure Global Ankylosing Spondylitis Revenue (Million USD) and Growth Rate of TNF Inhibitors (2017-2022)
Figure Global Ankylosing Spondylitis Sales Volume and Growth Rate of COX Inhibitors (2017-2022)
Figure Global Ankylosing Spondylitis Revenue (Million USD) and Growth Rate of COX Inhibitors (2017-2022)
Figure Global Ankylosing Spondylitis Sales Volume and Growth Rate of Others (2017-2022)
Figure Global Ankylosing Spondylitis Revenue (Million USD) and Growth Rate of Others (2017-2022)
Table Global Ankylosing Spondylitis Consumption by Application (2017-2022)
Table Global Ankylosing Spondylitis Consumption Market Share by Application (2017-2022)
Table Global Ankylosing Spondylitis Consumption Revenue (Million USD) by Application (2017-2022)
Table Global Ankylosing Spondylitis Consumption Revenue Market Share by Application (2017-2022)
Table Global Ankylosing Spondylitis Consumption and Growth Rate of Oral (2017-2022)
Table Global Ankylosing Spondylitis Consumption and Growth Rate of Parenteral (2017-2022)
Figure Global Ankylosing Spondylitis Sales Volume and Growth Rate Forecast (2022-2027)
Figure Global Ankylosing Spondylitis Revenue (Million USD) and Growth Rate Forecast (2022-2027)
Figure Global Ankylosing Spondylitis Price and Trend Forecast (2022-2027)
Figure USA Ankylosing Spondylitis Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure USA Ankylosing Spondylitis Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure Europe Ankylosing Spondylitis Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure Europe Ankylosing Spondylitis Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure China Ankylosing Spondylitis Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure China Ankylosing Spondylitis Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure Japan Ankylosing Spondylitis Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure Japan Ankylosing Spondylitis Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure India Ankylosing Spondylitis Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure India Ankylosing Spondylitis Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure Southeast Asia Ankylosing Spondylitis Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure Southeast Asia Ankylosing Spondylitis Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure Latin America Ankylosing Spondylitis Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure Latin America Ankylosing Spondylitis Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure Middle East and Africa Ankylosing Spondylitis Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure Middle East and Africa Ankylosing Spondylitis Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Table Global Ankylosing Spondylitis Market Sales Volume Forecast, by Type
Table Global Ankylosing Spondylitis Sales Volume Market Share Forecast, by Type
Table Global Ankylosing Spondylitis Market Revenue (Million USD) Forecast, by Type
Table Global Ankylosing Spondylitis Revenue Market Share Forecast, by Type
Table Global Ankylosing Spondylitis Price Forecast, by Type
Figure Global Ankylosing Spondylitis Revenue (Million USD) and Growth Rate of TNF Inhibitors (2022-2027)
Figure Global Ankylosing Spondylitis Revenue (Million USD) and Growth Rate of TNF Inhibitors (2022-2027)
Figure Global Ankylosing Spondylitis Revenue (Million USD) and Growth Rate of COX Inhibitors (2022-2027)
Figure Global Ankylosing Spondylitis Revenue (Million USD) and Growth Rate of COX Inhibitors (2022-2027)
Figure Global Ankylosing Spondylitis Revenue (Million USD) and Growth Rate of Others (2022-2027)
Figure Global Ankylosing Spondylitis Revenue (Million USD) and Growth Rate of Others (2022-2027)
Table Global Ankylosing Spondylitis Market Consumption Forecast, by Application
Table Global Ankylosing Spondylitis Consumption Market Share Forecast, by Application
Table Global Ankylosing Spondylitis Market Revenue (Million USD) Forecast, by Application
Table Global Ankylosing Spondylitis Revenue Market Share Forecast, by Application
Figure Global Ankylosing Spondylitis Consumption Value (Million USD) and Growth Rate of Oral (2022-2027)
Figure Global Ankylosing Spondylitis Consumption Value (Million USD) and Growth Rate of Parenteral (2022-2027)
Figure Ankylosing Spondylitis Industrial Chain Analysis
Table Key Raw Materials Suppliers and Price Analysis
Figure Manufacturing Cost Structure Analysis
Table Alternative Product Analysis
Table Downstream Distributors
Table Downstream Buyers
Table Shanghai Pharmaceuticals Profile
Table Shanghai Pharmaceuticals Ankylosing Spondylitis Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Shanghai Pharmaceuticals Ankylosing Spondylitis Sales Volume and Growth Rate
Figure Shanghai Pharmaceuticals Revenue (Million USD) Market Share 2017-2022
Table UCB Profile
Table UCB Ankylosing Spondylitis Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure UCB Ankylosing Spondylitis Sales Volume and Growth Rate
Figure UCB Revenue (Million USD) Market Share 2017-2022
Table Novartis Profile
Table Novartis Ankylosing Spondylitis Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Novartis Ankylosing Spondylitis Sales Volume and Growth Rate
Figure Novartis Revenue (Million USD) Market Share 2017-2022
Table Pfizer Profile
Table Pfizer Ankylosing Spondylitis Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Pfizer Ankylosing Spondylitis Sales Volume and Growth Rate
Figure Pfizer Revenue (Million USD) Market Share 2017-2022
Table Boehringer Ingelheim Profile
Table Boehringer Ingelheim Ankylosing Spondylitis Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Boehringer Ingelheim Ankylosing Spondylitis Sales Volume and Growth Rate
Figure Boehringer Ingelheim Revenue (Million USD) Market Share 2017-2022
Table Sanofi Profile
Table Sanofi Ankylosing Spondylitis Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Sanofi Ankylosing Spondylitis Sales Volume and Growth Rate
Figure Sanofi Revenue (Million USD) Market Share 2017-2022
Table Celgene Profile
Table Celgene Ankylosing Spondylitis Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Celgene Ankylosing Spondylitis Sales Volume and Growth Rate
Figure Celgene Revenue (Million USD) Market Share 2017-2022
Table Otsuka Pharmaceutical Profile
Table Otsuka Pharmaceutical Ankylosing Spondylitis Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Otsuka Pharmaceutical Ankylosing Spondylitis Sales Volume and Growth Rate
Figure Otsuka Pharmaceutical Revenue (Million USD) Market Share 2017-2022
Table Merck & Co. Profile
Table Merck & Co. Ankylosing Spondylitis Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Merck & Co. Ankylosing Spondylitis Sales Volume and Growth Rate
Figure Merck & Co. Revenue (Million USD) Market Share 2017-2022
Table Abbvie Profile
Table Abbvie Ankylosing Spondylitis Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Abbvie Ankylosing Spondylitis Sales Volume and Growth Rate
Figure Abbvie Revenue (Million USD) Market Share 2017-2022
Table F. Hoffmann-La Roche Profile
Table F. Hoffmann-La Roche Ankylosing Spondylitis Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure F. Hoffmann-La Roche Ankylosing Spondylitis Sales Volume and Growth Rate
Figure F. Hoffmann-La Roche Revenue (Million USD) Market Share 2017-2022
Table Regeneron Pharmaceuticals Profile
Table Regeneron Pharmaceuticals Ankylosing Spondylitis Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Regeneron Pharmaceuticals Ankylosing Spondylitis Sales Volume and Growth Rate
Figure Regeneron Pharmaceuticals Revenue (Million USD) Market Share 2017-2022
Table Celltrion Profile
Table Celltrion Ankylosing Spondylitis Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Celltrion Ankylosing Spondylitis Sales Volume and Growth Rate
Figure Celltrion Revenue (Million USD) Market Share 2017-2022
Table Bristol-Myers Squibb Profile
Table Bristol-Myers Squibb Ankylosing Spondylitis Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Bristol-Myers Squibb Ankylosing Spondylitis Sales Volume and Growth Rate
Figure Bristol-Myers Squibb Revenue (Million USD) Market Share 2017-2022
Table Eisai Profile
Table Eisai Ankylosing Spondylitis Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Eisai Ankylosing Spondylitis Sales Volume and Growth Rate
Figure Eisai Revenue (Million USD) Market Share 2017-2022
Table Amgen Profile
Table Amgen Ankylosing Spondylitis Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Amgen Ankylosing Spondylitis Sales Volume and Growth Rate
Figure Amgen Revenue (Million USD) Market Share 2017-2022
Table Janssen Pharmaceuticals Profile
Table Janssen Pharmaceuticals Ankylosing Spondylitis Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Janssen Pharmaceuticals Ankylosing Spondylitis Sales Volume and Growth Rate
Figure Janssen Pharmaceuticals Revenue (Million USD) Market Share 2017-2022
Table Merck Sharp & Dohme Profile
Table Merck Sharp & Dohme Ankylosing Spondylitis Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Merck Sharp & Dohme Ankylosing Spondylitis Sales Volume and Growth Rate
Figure Merck Sharp & Dohme Revenue (Million USD) Market Share 2017-2022


More Publications